Combinations of statins, aspirins and β-blockers improve survival in patients with ischaemic heart disease, say the UK authors of a case-control analysis.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
Correspondence:
Online responses are no longer available. Please refer to our instructions for authors page for more information.